Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Non-interventional Study

NCT00617214 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00617214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Non-interventional Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
January 31, 2008
Completion date
December 31, 2008
Enrollment
20 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

delusional disorder, psychotic disorder not otherwise specified, schizoaffective disorder, schizophreni-form disorder, schizophrenia